Incyte to Buy Vega Therapeutics For Up to $2 Billion
Incyte has agreed to buy Vega Therapeutics for up to $2 billion in a deal that expands the biopharmaceutical company’s hematology portfolio into bleeding disorders.
Connecting Global Economies
Flash News
The Bounce: The Knicks have history and experience on their side
Afghan women detained by Taliban in clothing crackdown
Iran announces ‘end of military operations’ against Israel
Neil Patrick Harris, David Burtka Detail Life With Twins Gideon, Harper
Rockets mailbag: Should Houston enter the Giannis Antetokounmpo market?
Johnson & Johnson to Buy Firefly Bio for $1 Billion
Opinion | Why Hong Kong matters to Kazakhstan’s financial ambitions
United CEO brushes off airline mergers after American rejection
British Artist Talay Riley Dead at 35 After Stabbing Incident
Iranian team wears #168 pins for victims of school strike: Will it be allowed during the World Cup?
Monday, June 08, 2026